ProPhase Labs Announces Significant Laboratory Expansion
June 13, 2022 08:30 ET | ProPhase Labs, Inc.
Expanding in-house clinical testing capabilities Initiates plans to build new genomics laboratory Garden City, NY, June 13, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a...
ProPhase Labs Announces Appointment of Bill White as Chief Financial Officer
May 10, 2022 08:15 ET | ProPhase Labs, Inc.
Garden City, NY, May 10, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified diagnostics and genomics company, announced today that Bill White has been appointed Chief...
ProPhase Labs Announces Record COVID-19 Testing in Q4 2021
January 13, 2022 08:15 ET | ProPhase Labs, Inc.
Q1 2022 Testing Volumes will Significantly Exceed Previous Record Results from Q1 2021 Significant year-over-year growth expected for the next four quarters Garden City, NY, Jan. 13, 2022 (GLOBE...
ProPhase Labs to Present at Two Upcoming August Conferences
August 16, 2021 08:30 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to...
ProPhase Labs Announces Financial Results for the Quarter Ended June 30, 2021
August 13, 2021 08:11 ET | ProPhase Labs, Inc.
Company Provides Update on Significant Resurgence in Covid testing and Additional Insights into Previously Announced Nebula Genomics Acquisition Company to hold a conference call today at...
ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics
August 11, 2021 08:30 ET | ProPhase Labs, Inc.
Nebula Founder and Renowned Harvard Scientist, George Church, Ph.D., to Spearhead ProPhase Labs New Scientific Advisory Board GARDEN CITY, NY, Aug. 11, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc....